| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1716 | 2019 |
| PD-1–expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer C Badoual, S Hans, N Merillon, C Van Ryswick, P Ravel, N Benhamouda, ... Cancer research 73 (1), 128-138, 2013 | 703 | 2013 |
| Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity E Mamessier, A Sylvain, ML Thibult, G Houvenaeghel, J Jacquemier, ... The Journal of clinical investigation 121 (9), 3609-3622, 2011 | 691 | 2011 |
| Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia RT Costello, S Sivori, E Marcenaro, M Lafage-Pochitaloff, ... Blood, The Journal of the American Society of Hematology 99 (10), 3661-3667, 2002 | 594 | 2002 |
| Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset C Harly, Y Guillaume, S Nedellec, CM Peigné, H Mönkkönen, ... Blood, The Journal of the American Society of Hematology 120 (11), 2269-2279, 2012 | 574 | 2012 |
| Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling F Pages, M Ragueneau, R Rottapel, A Truneh, J Nunes, J Imbert, D Olive Nature 369 (6478), 327-329, 1994 | 507 | 1994 |
| Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and … D Pende, S Marcenaro, M Falco, S Martini, ME Bernardo, D Montagna, ... Blood, The Journal of the American Society of Hematology 113 (13), 3119-3129, 2009 | 443 | 2009 |
| Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization S Pesce, M Greppi, G Tabellini, F Rampinelli, S Parolini, D Olive, ... Journal of Allergy and Clinical Immunology 139 (1), 335-346. e3, 2017 | 439 | 2017 |
| CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA … J Fourcade, Z Sun, O Pagliano, P Guillaume, IF Luescher, C Sander, ... Cancer research 72 (4), 887-896, 2012 | 420 | 2012 |
| Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype … C Fauriat, S Just-Landi, F Mallet, C Arnoulet, D Sainty, D Olive, ... Blood 109 (1), 323-330, 2007 | 419 | 2007 |
| CpG methylation controls reactivation of HIV from latency J Blazkova, K Trejbalova, F Gondois-Rey, P Halfon, P Philibert, ... PLoS pathogens 5 (8), e1000554, 2009 | 392 | 2009 |
| Human acute myeloid leukemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic … RT Costello, F Mallet, B Gaugler, D Sainty, C Arnoulet, JA Gastaut, ... Cancer research 60 (16), 4403-4411, 2000 | 383 | 2000 |
| PD-1 is a novel regulator of human B-cell activation ML Thibult, E Mamessier, J Gertner-Dardenne, S Pastor, S Just-Landi, ... International immunology 25 (2), 129-137, 2013 | 365 | 2013 |
| Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation R Lasserre, XJ Guo, F Conchonaud, Y Hamon, O Hawchar, AM Bernard, ... Nature chemical biology 4 (9), 538-547, 2008 | 337 | 2008 |
| BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination L Derré, JP Rivals, C Jandus, S Pastor, D Rimoldi, P Romero, O Michielin, ... The Journal of clinical investigation 120 (1), 157-167, 2010 | 331 | 2010 |
| PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma A Beldi-Ferchiou, M Lambert, S Dogniaux, F Vély, E Vivier, D Olive, ... Oncotarget 7 (45), 72961, 2016 | 303 | 2016 |
| CD8+ CD28− T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers G Filaci, D Fenoglio, M Fravega, G Ansaldo, G Borgonovo, P Traverso, ... The Journal of Immunology 179 (7), 4323-4334, 2007 | 302 | 2007 |
| A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission N Vey, JH Bourhis, N Boissel, D Bordessoule, T Prebet, A Charbonnier, ... Blood, The Journal of the American Society of Hematology 120 (22), 4317-4323, 2012 | 297 | 2012 |
| PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1 M Ghiotto, L Gauthier, N Serriari, S Pastor, A Truneh, JA Nunès, D Olive International immunology 22 (8), 651-660, 2010 | 276 | 2010 |
| Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome B Chetaille, F Bertucci, P Finetti, B Esterni, A Stamatoullas, JM Picquenot, ... Blood, The Journal of the American Society of Hematology 113 (12), 2765-3775, 2009 | 262 | 2009 |
